JP Morgan analyst Chris Schott maintains Eli Lilly and Co with a Overweight

By / / Eli Lilly

JP Morgan analyst Chris Schott maintains Eli Lilly and Co with a Overweight and raises the price target from $775 to $850.

Scroll to Top